Screener / SEC EDGAR /CIK 0001104506 /10-K filed Feb 19, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

INSMED Inc INSM

Compare with peers Embed
Planned sales, announced before they happen

5 trading plans running, 69 Form 144 notices for $149.3M

10-Q, 10-K and Form 144
Plans running now 5 William Lewis, Sara Bonstein, S. Nicole Schaeffer, Martina Flammer
Plans adopted 29 reported since May 4, 2023 Form 144 notices 69 $149.3M the sellers expected to sell

What INSM's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Aug 29, 2025 to Aug 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Michael A. Smith
Chief Legal Officer
Ended 10b5-1 plan Aug 27, 2026 10-Q Oct 29, 2026
William Lewis
Chief Executive Officer
Adopted 10b5-1 plan Aug 27, 2026 10-Q Oct 29, 2026
Sara Bonstein
Chief Financial Officer
Adopted 10b5-1 plan Aug 14, 2026 10-Q Oct 29, 2026
S. Nicole Schaeffer
Chief People Strategy Officer
Adopted 10b5-1 plan May 11, 2026 10-Q Aug 6, 2026
What the company wrote
Our policy governing transactions in our securities by our directors, officers and employees permits our directors, officers and employees to enter into trading plans complying with Rule 10b5-1 under the Exchange Act. The following table describes the written plans for the sale of our securities adopted, modified or terminated by our officers and directors (each as defined in Rule 16a-1(f) of the Exchange Act) during the second quarter of 2026, each of which was entered into during an open trading window and is intended to satisfy the affirmative defense conditions of Ru le 10b5-1(c) (each, a Trading Plan). Name and Title Date of Adoption of Trading Plan Scheduled Start Date of Trading Plan Scheduled Expiration Date of Trading Plan (1) Maximum Shares Subject to Trading Plan Date Plan Terminated S. Nicole Schaeffer Chief People Strategy Officer 05/11/2026 08/31/2026 12/01/2026 101,100 NA (1) A Trading Plan may expire on an earlier date if all contemplated transactions are completed before such Trading Plan’s expiration date, upon termination by broker or the holder of the Trading Plan, or as otherwise provided in the Trading Plan.
Martina Flammer
Adopted 10b5-1 plan Mar 16, 2026 10-Q May 7, 2026
Sara Bonstein
Adopted 10b5-1 plan Mar 3, 2026 10-Q May 7, 2026
Director
Elizabeth McKee Anderson
Ended 10b5-1 plan Dec 11, 2025 10-K Feb 19, 2026
Roger Adsett
Chief Operating Officer
Adopted 10b5-1 plan Dec 3, 2025 10-K Feb 19, 2026
S. Nicole Schaeffer
Chief People Strategy Officer
Adopted 10b5-1 plan Nov 12, 2025 10-K Feb 19, 2026
Sara Bonstein
Chief Financial Officer
Adopted 10b5-1 plan Nov 10, 2025 10-K Feb 19, 2026
Michael Smith
Chief Legal Officer
Ended 10b5-1 plan Nov 4, 2025 10-K Feb 19, 2026
William H. Lewis
Chair and CEO
Adopted 10b5-1 plan Sep 4, 2025 10-Q Oct 30, 2025
S. Nicole Schaeffer
Chief People Strategy Officer
Adopted 10b5-1 plan Aug 29, 2025 10-Q Oct 30, 2025
S. Nicole Schaeffer
Chief People Strategy Officer
Adopted 10b5-1 plan Jun 13, 2025 10-Q Aug 7, 2025
Sara Bonstein
Chief Financial Officer
Adopted 10b5-1 plan Mar 5, 2025 10-Q May 8, 2025
David W.J. McGirr
Director
Adopted 10b5-1 plan Mar 4, 2025 10-Q May 8, 2025
Roger Adsett
Chief Operating Officer
Adopted 10b5-1 plan Mar 4, 2025 10-Q May 8, 2025
Martina Flammer
Chief Medical Officer
Adopted 10b5-1 plan Feb 27, 2025 10-Q May 8, 2025
Michael Smith
Chief Legal Officer
Adopted 10b5-1 plan Feb 27, 2025 10-Q May 8, 2025
S. Nicole Schaeffer
Chief People Strategy Officer
Adopted 10b5-1 plan Feb 26, 2025 10-Q May 8, 2025
Alfred Altomari
Director
Adopted 10b5-1 plan Feb 24, 2025 10-Q May 8, 2025
William Lewis
Adopted 10b5-1 plan Sep 12, 2024 10-Q Oct 31, 2024
Sara Bonstein
Adopted 10b5-1 plan Aug 23, 2024 10-Q Oct 31, 2024
S.Nicole Schaeffer
Adopted 10b5-1 plan Aug 15, 2024 10-Q Oct 31, 2024
Michael Smith
Chief Legal Officer
Adopted 10b5-1 plan Jun 13, 2024 10-Q Aug 8, 2024
S.Nicole Schaeffer2
Adopted 10b5-1 plan Jun 11, 2024 10-Q Aug 8, 2024
Martina Flammer
Chief Medical Officer
Adopted 10b5-1 plan Jun 7, 2024 10-Q Aug 8, 2024
S. Nicole Schaeffer
Chief People Strategy Officer
Ended 10b5-1 plan Jun 7, 2024 10-Q Aug 8, 2024
Drayton Wise
Chief Commercial Officer
Adopted 10b5-1 plan Feb 27, 2024 10-Q May 9, 2024
S. Nicole Schaeffer
Chief People Strategy Officer
Adopted 10b5-1 plan Feb 27, 2024 10-Q May 9, 2024
Sara Bonstein
Chief Financial Office
Adopted 10b5-1 plan Feb 27, 2024 10-Q May 9, 2024
William Lewis
Chief Executive Officer
Ended 10b5-1 plan Feb 26, 2024 10-Q May 9, 2024
Michael A. Smith
Chief Legal Officer
Adopted 10b5-1 plan Dec 14, 2023 10-K Feb 22, 2024
What the company wrote
Michael A. Smith, our Chief Legal Officer, entered into a prearranged stock trading arrangement (the Trading Plan) on December 14, 2023. Mr. Smith’s Trading Plan provides for the sale of an aggregate number of up to 44,722 shares of the Company's common stock between March 15, 2024 and September 16, 2024. The Trading Plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and the Company’s policies regarding insider transactions.
Sara Bonstein
Chief Financial Officer
Adopted plan Sep 15, 2023 10-Q Oct 26, 2023
Show the other 26 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 3, 2026 Sara Bonstein
Former Officer
10,261 $1.1M
Sep 10, 2026 Brennan David R
Director
25,000 $3.1M
Aug 17, 2026 MELVIN SHAROKY
Director
5,000 $638K
Aug 10, 2026 Roger Adsett
Officer
239,850 $32.0M
Aug 6, 2026 Martina Flammer
Officer
27,173 $3.5M
Jul 23, 2026 William Lewis
Officer
10,700 $1.1M
Jul 9, 2026 William Lewis
Officer
10,699 $1.3M
Jul 6, 2026 Martina Flammer
Officer
12,302 $1.4M
Jun 25, 2026 William Lewis
Officer
21,398 $2.2M
Jun 22, 2026 Michael Smith
Officer
1,806 $173K
Jun 8, 2026 William Lewis
Officer
6,515 $613K
Jun 5, 2026 Martina Flammer
Officer
1,858 $193K
Jun 3, 2026 Sara Bonstein
Officer
2,404 $246K
Jun 3, 2026 Martina Flammer
Officer
2,566 $262K
Jun 3, 2026 Roger Adsett
Officer
2,370 $242K
Jun 3, 2026 Michael Smith
Officer
2,159 $221K
Jun 3, 2026 William Lewis
Officer
7,605 $778K
May 22, 2026 Michael Smith
Officer
6,149 $667K
May 18, 2026 William Lewis
Officer
25,564 $2.7M
May 14, 2026 Martina Flammer
Officer
10,479 $1.2M
May 13, 2026 Roger Adsett
Officer
5,837 $678K
May 13, 2026 Michael Smith
Officer
4,109 $477K
May 13, 2026 Sara Bonstein
Officer
8,272 $961K
May 13, 2026 Martina Flammer
Officer
7,854 $897K
May 13, 2026 William Lewis
Officer
13,283 $1.5M
May 11, 2026 Martina Flammer
Officer
12,949 $1.3M
May 4, 2026 William Lewis
Officer
10,699 $1.5M
Apr 16, 2026 William Lewis
Officer
10,699 $1.5M
Apr 6, 2026 William Lewis
Officer
10,699 $1.7M
Apr 1, 2026 Roger Adsett
Officer
88,060 $14.5M
Mar 30, 2026 Michael Smith
Officer
19,638 $3.0M
Mar 19, 2026 William Lewis
Officer
10,699 $1.5M
Mar 5, 2026 William Lewis
Officer
10,699 $1.6M
Feb 24, 2026 Michael Smith
Officer
24,774 $3.9M
Feb 19, 2026 William Lewis
Officer
10,699 $1.6M
Feb 9, 2026 William Lewis
Officer
13,396 $2.0M
Feb 5, 2026 Martina Flammer
Officer
869 $132K
Feb 3, 2026 Roger Adsett
Officer
791 $124K
Feb 3, 2026 Michael Smith
Officer
640 $100K
Feb 3, 2026 William Lewis
Officer
3,009 $470K
Feb 3, 2026 Martina Flammer
Officer
795 $124K
Feb 3, 2026 Sara Bonstein
Officer
748 $117K
Feb 2, 2026 Martina Flammer
Officer
7,982 $1.2M
Jan 20, 2026 William Lewis
Officer
10,699 $1.7M
Jan 12, 2026 William Lewis
Officer
19,215 $3.2M
Jan 8, 2026 Sara Bonstein
Officer
1,447 $252K
Jan 8, 2026 Martina Flammer
Officer
5,138 $895K
Jan 8, 2026 Martina Flammer
Officer
1,660 $289K
Jan 8, 2026 Roger Adsett
Officer
2,059 $359K
Jan 8, 2026 Michael Smith
Officer
1,053 $183K
Jan 8, 2026 William Lewis
Officer
3,223 $561K
Jan 7, 2026 Roger Adsett
Officer
802 $140K
Jan 7, 2026 Michael Smith
Officer
709 $124K
Jan 7, 2026 William Lewis
Officer
2,357 $413K
Jan 7, 2026 Sara Bonstein
Officer
1,678 $294K
Jan 7, 2026 Martina Flammer
Officer
1,434 $252K
Jan 6, 2026 Sara Bonstein
Officer
1,517 $263K
Jan 6, 2026 Martina Flammer
Officer
1,615 $280K
Jan 6, 2026 Roger Adsett
Officer
1,429 $248K
Jan 6, 2026 Michael Smith
Officer
1,396 $242K
Jan 6, 2026 William Lewis
Officer
4,096 $710K
Jan 5, 2026 Martina Flammer
Officer
20,873 $3.6M
Jan 2, 2026 Stacey Nicole Schaeffer Orlov
Officer
87,290 $15.3M
Dec 18, 2025 William Lewis
Officer
10,699 $1.8M
Dec 5, 2025 MELVIN SHAROKY
DIRECTOR
20,000 $4.1M
Dec 4, 2025 William Lewis
Officer
10,699 $2.2M
Dec 1, 2025 Martina Flammer
Officer
8,895 $1.8M
Nov 24, 2025 ANDERSON ELIZABETH M
Director
5,000 $1.0M
Nov 17, 2025 Leo Lee
Director
75,000 $14.5M
Show the other 61 notices

From the Form 144 XML filed with the SEC, since Nov 17, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/INSM/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.